April 25, 2018 / 6:13 AM / in 3 months

BRIEF-Novozymes Q1 EBIT Above Expectations At DKK 1.02 Billion

April 25 (Reuters) - NOVOZYMES A/S:

* REG-INTERIM REPORT FOR THE FIRST THREE MONTHS OF 2018

* FULL-YEAR 2018 OUTLOOK MAINTAINED

* Q1 EBIT DKK 1.02 BILLION (REUTERS POLL DKK 990 MILLION)

* “THERE IS STILL SOME UNCERTAINTY IN THE AGRICULTURE-RELATED BUSINESS, INCLUDING FROM RECENT GEOPOLITICAL TENSIONS”

* Q1 SALES DKK 3.52 BILLION (REUTERS POLL DKK 3.61 BILLION)

* “THERE IS STILL SOME UNCERTAINTY IN THE AGRICULTURE-RELATED BUSINESS, INCLUDING FROM RECENT GEOPOLITICAL TENSIONS”

* Q1 ORGANIC SALES GROWTH OF 2% AND -6% IN DKK. USD/DKK DECLINE OF 13% IN Q1 Y/Y

* Q1 NET PROFIT DKK 807 MILLION (REUTERS POLL DKK 778 MILLION)

* “WE REMAIN FIRM ABOUT ACCELERATING SALES GROWTH THROUGHOUT 2018 AND BEYOND.” - CEO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below